Peiting Zeng

1PUBLICATIONS
7CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 24, 2024
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.

Jiang-Jiang Li, Tiantian Yu, Peiting Zeng

Pageof 1

Frequent Collaborators

1 joint publications

Jiang-Jiang Li

1 joint publications

Tiantian Yu

1 joint publications

Panpan Liu

1 joint publications

Shuang Qiao